Memory Problems Could Be Early Alzheimer’s Act Now!

What Are the Symptoms of Alzheimer’s Disease?
Common symptoms of early Alzheimer’s include:

• Loss of memory that affects daily living – You may find that you rely more on notes or family members to remember appointments or things that you used to handle on your own.

• Poor judgment leading to unusual decision-making — You might forget to pay bills, or pay less attention to personal grooming.

• Challenges in planning or problem-solving — Following a plan or a recipe may be more difficult, or your concentration may be easily broken.

• Difficulty completing familiar tasks — You may forget where everyday items are kept, how to use a device, or how to get somewhere you visit frequently.

• Confusion with time and place — You may lose track of the date and the passage of time, when events occurred, or not understand where you are or how you got there.

• Trouble understanding visual images — You might have difficulty reading or judging distance, which can cause issues with your balance.

• Losing things and having trouble retracing steps — You might put things in an unusual place or mistakenly blame others for hiding things from you.

• Withdrawing from social activities — You may drop out of conversations or have trouble finding certain words.

• Changes in mood and personality — You may become more irritable, easily frustrated, or upset when outside of familiar surroundings.

None of these are enough by themselves to make a diagnosis. But if you or someone you know are experiencing any of these symptoms, call Renstar today to learn about a new Alzheimer’s Disease trial.

Tell Me More About the TRAVELLER Study

WHO CAN PARTICIPATE?
Individuals 50-90 years old who:
• have memory concerns reported by them or a doctor within the last year;
• have not previously had a diagnosis of Alzheimer’s disease based on an amyloid PET scan or cerebrospinal fluid draw;
• are able to complete daily, basic tasks that are not affected by memory or cognitive concerns;
• do not have other neurodegenerative conditions or major psychiatric conditions;
• has not chronically used antipsychotic or neuroleptic medications within last 3 months;
• has not abused alcohol or substances within the last 6 months.

WHAT IS REQUIRED TO PARTICIPATE?
For this prescreening program, participants will be asked to do the following:
• sign an informed consent document;
• provide information about their medical history, baseline conditions, and medications usage;
• provide demographic data, including their age, sex, and self-reported race or ethnicity;
• complete a learning and memory task assessment;
• complete a blood draw for standard blood tests and to determine ptau217 (ptau217 is a protein that is elevated in the blood of individuals with Alzheimer’s
disease).

Why Should I Participate In an Alzheimer’s Clinical Trial?

Reasons to participate can include:
• people 60+ years old have a 1 in 6 chance of developing harmful levels of amyloid beta, a protein associated with Alzheimer’s disease;
• participating in research expands your options, especially if you have been offered limited treat-ments or have tried treatments you could not tolerate, afford, or found effective;
• once enrolled in trial, you receive regularly scheduled monitoring by specialized health professionals at no cost to you or your insurance;
• you can make a difference! Your participation in this study will help contribute to scientific research that

About Renstar Medical Research
Founded in 1998, Renstar Medical Research has been at the forefront of clinical research, dedicated to advancing medical breakthroughs through high-quality, multispecialty clinical trials. With over two decades of experience, we have conducted studies across a wide range of therapeutic areas, including obesity, chronic obstructive pulmonary disease (COPD), Alzheimer’s disease, Parkinson’s disease, psoriasis, and other conditions.

Through innovation, expertise, and a patient-centered approach, we strive to make a meaningful impact on global healthcare. At Renstar Medical Research, we are seeking tomorrow’s answers to the health questions of today.

For more information about an Alzheimer’s clinical trial and to determine if you qualify, contact Renstar Medical Research today.

Renstar Medical Research
352-629-5800